The antidepressant sertraline prevents the behavioral and EEG changes induced in two animal models of seizures

Epilepsy and Behavior

Volumn 25, Issue 4, 2012, Pages 511-516

  Sitges, María ^a   Aldana, Blanca I ^a   Gómez, Carlos D ^a   Nekrassov, Vladimir ^b  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

4 aminopyridine; Carbamazepine; Depression in epilepsy; Pentylenetetrazole

Indexed keywords

CARBAMAZEPINE; PENTETRAZOLE; SERTRALINE;

AMPLITUDE MODULATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DISEASE MODEL; ELECTRODE; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; INHIBITION KINETICS; LATENT PERIOD; MALE; MOTOR ACTIVITY; NONHUMAN; RAT; REFLEX; SINGLE DRUG DOSE; TONIC CLONIC SEIZURE; TREMOR;

4-AMINOPYRIDINE; ANIMALS; ANTICONVULSANTS; BRAIN; CARBAMAZEPINE; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EXPLORATORY BEHAVIOR; MALE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; SEIZURES; SERTRALINE; VOCALIZATION, ANIMAL;

EID: 84871831548     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.09.005     Document Type: Article

References (26)

1. Kanner A.M. Depression in epilepsy: a complex relation with unexpected consequences. Curr Opin Neurol 2008, 21:190-194.
2. Kanner A.M., Trimble M., Schmitz B. Postictal affective episodes. Epilepsy Behav 2010, 19:156-158.
3. Noe K.H., Locke D.E., Sirven J.I. Treatment of depression in patients with epilepsy. Curr Treat Options Neurol 2011, 13:371-379.
4. Danzer S.C. Depression, stress, epilepsy and adult neurogenesis. Exp Neurol 2011, 233:22-32.
5. Stevanovic D., Jancic J., Lakic A. The impact of depression and anxiety disorder symptoms on the health-related quality of life of children and adolescents with epilepsy. Epilepsia 2011, 52:e75-e78.
6. Mula M. Epilepsy: bidirectional link between epilepsy and psychiatric disorders. Nat Rev Neurol 2012, 8:252-253.
7. Preskorn S.H., Fast G.A. Tricyclic antidepressant-induced seizures and plasma drug concentration. J Clin Psychiatry 1992, 53:160-162.
8. Pisani F., Oteri G., Costa C., Di Raimondo G., Di Perri R. Effects of psychotropic drugs on seizure threshold. Drug Saf 2002, 25:91-110.
9. Alper K., Schwartz K.A., Kolts R.L., Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry 2007, 62:345-354.
10. Tatsumi M., Groshan K., Blakely R.D., Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 1997, 340:249-258.
11. Sheehan D.V., Kamijima K. An evidence-based review of the clinical use of sertraline in mood and anxiety disorders. Int Clin Psychopharmacol 2009, 24:43-60.
12. Seethalakshmi R., Krishnamoorthy E.S. Depression in epilepsy: phenomenology, diagnosis and management. Epileptic Disord 2007, 9:1-10.
13. Sitges M., Chiu L.M., Nekrassov V. Single and combined effects of carbamazepine and vinpocetine on depolarization-induced changes in Na(+), Ca(2+) and glutamate release in hippocampal isolated nerve endings. Neurochem Int 2006, 49:55-61.
14. Sitges M., Chiu L.M., Nekrassov V. Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings. Neuropharmacology 2007, 52:598-605.
15. + channel mediated responses in hippocampus isolated nerve endings. J Neurochem 2012, 121:197-205.
16. Tremaine L.M., Welch W.M., Ronfeld R.A. Metabolism and disposition of the 5-hydroxytryptamine uptake blocker sertraline in the rat and dog. Drug Metab Dispos 1989, 17:542-550.
17. Graumlich J.F., McLaughlin R.G., Birkhahn D., et al. Subcutaneous microdialysis in rats correlates with carbamazepine concentrations in plasma and brain. Epilepsy Res 2000, 40:25-32.
18. Nekrassov V., Sitges M. Effects of pentylenetetrazole and 4-aminopyridine on the auditory brainstem response (ABR) and on the hearing sensitivity in the guinea pig in vivo. Epilepsy Res 2003, 53:245-254.
19. Mihály A., Bencsik K., Solymosi T. Naltrexone potentiates 4-aminopyridine seizures in the rat. J Neural Transm (GenSect) 1990, 79:59-67.
20. Weiczner R., Krisztin-Péva B., Mihály A. Blockade of AMPA-receptors attenuates 4-aminopyridine seizures, decreases the activation of inhibitory neurons but is ineffective against seizure-related astrocytic swelling. Epilepsy Res 2008, 78:22-32.
21. Akamatsu N., Fueta Y., Endo Y., Matsunaga K., Uozumi T., Tsuji S. Decreased susceptibility to pentylenetetrazol-induced seizures after low-frequency transcranial magnetic stimulation in rats. Neurosci Lett 2001, 310:153-156.
22. López-Meraz M.L., González-Trujano M.E., Neri-Bazán L., Hong E., Rocha L.L. 5-HT1A receptor agonists modify epileptic seizures in three experimental models in rats. Neuropharmacology 2005, 49:367-375.
23. Galván E., Sitges M. Characterization of the participation of sodium channels on the rise in Na+ induced by 4-aminopyridine (4-AP) in synaptosomes. Neurochem Res 2004, 29:347-355.
24. Macdonald R.L., Barker J.L. Pentylenetetrazol and penicillin are selective antagonists of GABA-mediated post-synaptic inhibition in cultured mammalian neurones. Nature 1977, 267:720-721.
25. Huang R.Q., Bell-Horner C.L., Dibas M.I., Covey D.F., Drewe J.A., Dillon G.H. Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action. J Pharmacol Exp Ther 2001, 298:986-995.
26. Sitges M., Nekrassov V. Vinpocetine prevents 4-aminopyridine-induced changes in the EEG, the auditory brainstem responses and hearing. Clin Neurophysiol 2004, 115:2711-2717.